Crossmark

Designed Ankyrin Repeat Protein (DARPin) to target chimeric antigen receptor (CAR)-redirected T cells towards CD4+ T cells to reduce the latent HIV+ cell reservoir

Crossref DOI link: https://doi.org/10.1007/s00430-020-00692-0

Published Online: 2020-09-12

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Patasic, Lea

Seifried, Janna https://orcid.org/0000-0002-7015-6647
Bezler, Valerie

Kaljanac, Marcell

Schneider, Irene C.

Schmitz, Heike

Tondera, Christiane

Hartmann, Jessica

Hombach, Andreas

Buchholz, Christian J.

Abken, Hinrich

König, Renate https://orcid.org/0000-0003-4882-9179
Cichutek, Klaus
Funding

Funding for this research was provided by:

Deutsches Zentrum für Infektionsforschung (TTU 04.802)

Paul-Ehrlich-Institut - Bundesinstitut f├╝r Impfstoffe und biomedizinische Arzneimittel
License Information

Text and Data Mining valid from 2020-09-12

Version of Record valid from 2020-09-12
More Information

Article History

Received: 16 September 2019

Accepted: 19 August 2020

First Online: 12 September 2020

Compliance with ethical standards

:

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below